Doctors are finding blood clots in the lungs, heart, and kidneys of coronavirus patients. Some of them are critically ill, but others seem relatively stable.
Blood clots can travel and create blockages in veins, which could lead to strokes, heart attacks, and other issues.
Without clinical trials or science-backed treatments, physicians are forced to figure out how to best treat these complications on "very weak but very compelling data," Dr. Alex Spyropoulos, an expert on blood clots at Northwell Health in New York, told Business Insider.
Business Insider talked to Michael Reagan, a 49-year-old COVID-19 patient whose doctors recently discovered dozens of blood clots in his lungs.
Read live updates about the coronavirus here.
Related Video: Why Some Viruses Jump From Animals to People and Some Don't
More than 2 million people around the world have been infected with the novel coronavirus, but there's still a lot we don't know about how the disease affects the human body.
Respiratory issues are one of the key symptoms of infection, but other complications — like kidney issues and heart problems — have more recently risen to the surface as physicians struggle to better understand how to treat their patients.
With COVID-19, the disease caused by the coronavirus, doctors are also seeing blood clots occurring in the lungs and bodies of patients. Clots can travel and create blockages in veins, leading to strokes, heart attacks, and other issues.
Some of the patients with blood clots are in hospitals in critical condition while others diagnosed with the complications are otherwise healthy enough to be sent home.
That's what happened to Michael Reagan, a 49-year-old COVID-19 patient.
'It feels like a toxin is in my body'
Reagan, who works for an international biomedical company in New York, was diagnosed with COVID-19 in late March and had been recovering at home in New York City for weeks. He was taking azithromycin, an antibiotic used to treat infections, and hydroxychloroquine, an anti-malarial medication, as a participant in a clinical trial.
Blood clots can travel and create blockages in veins, which could lead to strokes, heart attacks, and other issues.
Without clinical trials or science-backed treatments, physicians are forced to figure out how to best treat these complications on "very weak but very compelling data," Dr. Alex Spyropoulos, an expert on blood clots at Northwell Health in New York, told Business Insider.
Business Insider talked to Michael Reagan, a 49-year-old COVID-19 patient whose doctors recently discovered dozens of blood clots in his lungs.
Read live updates about the coronavirus here.
Related Video: Why Some Viruses Jump From Animals to People and Some Don't
More than 2 million people around the world have been infected with the novel coronavirus, but there's still a lot we don't know about how the disease affects the human body.
Respiratory issues are one of the key symptoms of infection, but other complications — like kidney issues and heart problems — have more recently risen to the surface as physicians struggle to better understand how to treat their patients.
With COVID-19, the disease caused by the coronavirus, doctors are also seeing blood clots occurring in the lungs and bodies of patients. Clots can travel and create blockages in veins, leading to strokes, heart attacks, and other issues.
Some of the patients with blood clots are in hospitals in critical condition while others diagnosed with the complications are otherwise healthy enough to be sent home.
That's what happened to Michael Reagan, a 49-year-old COVID-19 patient.
'It feels like a toxin is in my body'
Reagan, who works for an international biomedical company in New York, was diagnosed with COVID-19 in late March and had been recovering at home in New York City for weeks. He was taking azithromycin, an antibiotic used to treat infections, and hydroxychloroquine, an anti-malarial medication, as a participant in a clinical trial.
SHARE THIS POST
0 comments:
Post a Comment